MRI vendor Fonar of Melville, NY, has received a patent for MRIbreast scanning of multiple patients, the company reported thismonth. The technique could be used with Fonar's new Quad seriesof MRI magnets, which are open on all four sides and can be
MRI vendor Fonar of Melville, NY, has received a patent for MRIbreast scanning of multiple patients, the company reported thismonth. The technique could be used with Fonar's new Quad seriesof MRI magnets, which are open on all four sides and can be fittedwith up to four patient beds, with a screen between the patientsas they are shuttled through the magnet.
Fonar hopes that the multiple-bed configuration will increasethe throughput and reduce the cost of breast MRI scanning enoughto make it competitive with conventional x-ray mammography. Theconfiguration allows as many as 10 patients to be scanned in anhour, according to Fonar.
Fonar has aggressively defended other MRI patents against whatit claims are infringements by other vendors. It has settled claimsagainst Hitachi and Philips and is involved in litigation withGE, Siemens, and Toshiba.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.